Older Age at Diagnosis and Initial Disease Volume Predict Grade Reclassification Risk on Confirmatory Biopsy in Patients Considered for Active Surveillance

被引：0
|
作者：
Singhal, Udit [1 ]
George, Arvin K.
Tosoian, Jeffrey J.
机构：
[1] Univ Michigan, Dept Urol, Ann Arbor, MI 48109 USA
来源：
UROLOGY | 2019年 / 130卷
关键词：
PROSTATE-CANCER; MEN;
D O I：
10.1016/j.urology.2019.02.051
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：111 / 112
页数：2
相关论文
共 50 条
  • [41] Validating the total cancer location density metric for stratifying patients with low-risk localized prostate cancer at higher risk of grade group reclassification while on active surveillance
    Tan, Guan Hee
    Deniffel, Dominik
    Finelli, Antonio
    Wettstein, Marian
    Ahmad, Ardalan
    Zlotta, Alexandre
    Fleshner, Neil
    Hamilton, Robert
    Kulkarni, Girish
    Nason, Gregory
    Ajib, Khaled
    Herrera-Caceres, Jaime
    Chandrasekar, Thenappan
    Perlis, Nathan
    [J]. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2023, 41 (03) : 146.e23 - 146.e28
  • [42] Magnetic Resonance Imaging Targeted Biopsy Improves Selection of Patients Considered for Active Surveillance for Clinically Low Risk Prostate Cancer Based on Systematic Biopsies
    Ouzzane, Adil
    Renard-Penna, Raphaele
    Marliere, Francois
    Mozer, Pierre
    Olivier, Jonathan
    Barkatz, Johann
    Puech, Philippe
    Villers, Arnauld
    [J]. JOURNAL OF UROLOGY, 2015, 194 (02): : 350 - 356
  • [43] MAGNETIC RESONANCE IMAGING AND ULTRASOUND FUSION BIOPSY IN FOLLOW-UP OF PATIENTS IN ACTIVE SURVEILLANCE PROTOCOL. CAN PSA DENSITY DISCRIMINATE PATIENTS AT HIGHER RISK OF RECLASSIFICATION?
    La Croce, Giovanni
    Stabile, Armando
    Lughezzani, Giovanni
    Pepe, Pietro
    Galosi, Andrea
    Nicolai, Maria
    Naselli, Angelo
    Sironi, Sandro
    Luca, Balzarini
    Guazzoni, Giorgio
    Briganti, Alberto
    Montorsi, Francesco
    Da Pozzo, Luigi Filippo
    Roscigno, Marco
    [J]. ANTICANCER RESEARCH, 2019, 39 (03) : 1554 - 1555
  • [44] A nomogram based on an extended biopsy strategy predicting low-volume/low-grade prostate cancer: A tool in selecting active surveillance patients
    Nakanishi, H.
    Wang, X.
    Ochiai, A.
    Trpkov, K.
    Yilmaz, A.
    Donnelly, J. B.
    Troncoso, P.
    Davis, J.
    Babaian, R. J.
    [J]. EUROPEAN UROLOGY SUPPLEMENTS, 2007, 6 (02) : 202 - 202
  • [45] The secondary evaluation of biopsy tissue for initial prostate cancer diagnosis: does a dedicated uro-pathologist change therapy recommendation in active surveillance patients?
    Knipper, S.
    Arnold, C.
    Heinzer, H.
    Lutz, F.
    Sauter, G.
    Graefen, M.
    [J]. EUROPEAN UROLOGY, 2021, 79 : S1454 - S1454
  • [46] PATIENTS THAT DEMONSTRATE GLEASON 6 VOLUME PROGRESSION ON ACTIVE SURVEILLANCE HAVE A SUBSTANTIALLY GREATER RISK OF GRADE PROGRESSION ON FURTHER FOLLOW-UP
    Komisarenko, Maria
    Wong, Li-Ming
    Richard, Patrick
    Timilshina, Narhari
    Toi, Ants
    Evans, Andrew
    Zlotta, Alexandre
    Kulkarni, Girish
    Hamilton, Robert
    Fleshner, Neil
    Finelli, Antonio
    [J]. JOURNAL OF UROLOGY, 2014, 191 (04): : E720 - E720
  • [47] Computer Extracted Features from Initial H&E Tissue Biopsies Predict Disease Progression for Prostate Cancer Patients on Active Surveillance
    Chandramouli, Sacheth
    Leo, Patrick
    Lee, George
    Elliott, Robin
    Davis, Christine
    Zhu, Guangjing
    Fu, Pingfu
    Epstein, Jonathan I.
    Veltri, Robert
    Madabhushi, Anant
    [J]. CANCERS, 2020, 12 (09) : 1 - 11
  • [48] Abnormal findings on multiparametric prostate magnetic resonance imaging predict subsequent biopsy upgrade in patients with low risk prostate cancer managed with active surveillance
    Robert R. Flavell
    Antonio C. Westphalen
    Carmin Liang
    Christopher C. Sotto
    Susan M. Noworolski
    Daniel B. Vigneron
    Zhen J. Wang
    John Kurhanewicz
    [J]. Abdominal Imaging, 2014, 39 : 1027 - 1035
  • [49] Abnormal findings on multiparametric prostate magnetic resonance imaging predict subsequent biopsy upgrade in patients with low risk prostate cancer managed with active surveillance
    Flavell, Robert R.
    Westphalen, Antonio C.
    Liang, Carmin
    Sotto, Christopher C.
    Noworolski, Susan M.
    Vigneron, Daniel B.
    Wang, Zhen J.
    Kurhanewicz, John
    [J]. ABDOMINAL IMAGING, 2014, 39 (05): : 1027 - 1035
  • [50] %p2PSA and phi predict the pathological reclassification of first-year protocol biopsy during Active surveillance for early prostate cancer patients: From the PRIAS-JAPAN study
    Takuma, K.
    Hirama, H.
    Koji, M.
    Satoru, M.
    Hiroshi, S.
    Toshihiro, S.
    Ryuji, M.
    Shinichi, S.
    Yasuyuki, S.
    Hiroshi, F.
    Yukio, N.
    Hiromasa, T.
    Isao, H.
    Osamu, O.
    Katsuyoshi, H.
    Fumimasa, F.
    Akira, Y.
    Yoichiro, T.
    Yoshiyuki, K.
    Mikio, S.
    [J]. EUROPEAN UROLOGY, 2021, 79 : S1464 - S1465
12345